Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

KNSAKNSA
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in KINIKSA PHARMACEUTICALS INTE

Yes. Vanguard Portfolio Management holds 1,911,335 shares of KNSA (Kiniksa Pharmaceuticals Inte), worth $122.2M, as of its Q2 2026 13F filing. It increased the position by 145,067 shares (+8.2%) from Q1 2026. Vanguard Portfolio Management has held KNSA in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$122.2M

Current Shares

1.9M

Total Value Change

+$37.2M

Total Shares Change

+145,067

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+8.2%
$122.2M0.0%$63.95
33
2026-Q1
First report
1.8M
-
$85M0.0%$48.15
0

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used